The Doxepin Test is a specialized medical examination conducted to detect and measure the levels of Doxepin, a tricyclic antidepressant, in the body. This test is crucial for individuals who are prescribed Doxepin for the treatment of depression, anxiety disorders, or insomnia, as it helps in monitoring the drug's concentration in the bloodstream to ensure therapeutic efficacy and avoid potential toxicity. The test is performed by collecting a blood sample from the patient, which is then analyzed using advanced laboratory techniques.
At DNA Labs UAE, a leading healthcare and diagnostic center, the Doxepin Test is offered as part of their comprehensive suite of diagnostic services. The test is conducted by experienced professionals using state-of-the-art equipment to ensure accurate and reliable results. The cost of the Doxepin Test at DNA Labs UAE is 1320 AED, reflecting the quality and precision of the diagnostic services provided.
Patients opting for this test at DNA Labs UAE can expect a seamless and comfortable experience, with guidance provided throughout the testing process. The results of the test are typically available within a few days, allowing for prompt adjustments to the patient's medication regimen if necessary. This test is a valuable tool for healthcare providers in optimizing the treatment plan for patients taking Doxepin, ensuring both safety and effectiveness in managing their conditions.
The "FISH - t(8;21) or LSI ETOAML1 Test" is a specialized diagnostic procedure aimed at detecting the translocation between chromosomes 8 and 21, often denoted as t(8;21). This genetic anomaly is particularly significant in the context of acute myeloid leukemia (AML), where it serves as a critical diagnostic and prognostic marker. The test employs Fluorescence In Situ Hybridization (FISH) technology, a powerful technique that allows for the visualization of specific genetic abnormalities within chromosomes, directly in the cells.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test is priced at 1200 AED. This cost covers the sophisticated FISH technique which involves the use of fluorescent probes that specifically bind to the regions of interest on chromosomes 8 and 21. The presence of a fluorescent signal at the expected locations indicates the t(8;21) translocation, providing crucial information for the diagnosis, treatment planning, and prognosis of AML patients.
By offering this test, DNA Labs UAE contributes significantly to the personalized management of leukemia, facilitating targeted therapies that can greatly improve patient outcomes. The accuracy, reliability, and specificity of the FISH - t(8;21) or LSI ETOAML1 Test make it an invaluable tool in the field of medical genetics and oncology.
The "FISH - Opposite Sex BMT XX XY Test" offered by DNA Labs UAE is a specialized diagnostic procedure designed to assess the success of a bone marrow transplant (BMT) by identifying the presence of cells from a donor of the opposite sex in the recipient's bloodstream. This test is particularly relevant in cases where a male patient receives a transplant from a female donor or vice versa.
Fluorescence In Situ Hybridization (FISH) technology is employed in this test to detect specific DNA sequences on the X and Y chromosomes, allowing for the precise identification of male (XY) and female (XX) cells within a sample. This method is highly sensitive and accurate, making it an invaluable tool in post-transplant monitoring. By evaluating the proportion of donor to recipient cells, healthcare providers can assess the transplant's engraftment success and monitor for potential complications.
The test is priced at 1200 AED and is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. Patients or healthcare providers interested in this test should contact DNA Labs UAE directly for more detailed information regarding preparation, appointment scheduling, and any specific requirements related to the test.
The "FISH - PDGFR Alpha 4q12 Gene Rearrangement Test" is a sophisticated diagnostic procedure aimed at detecting rearrangements in the PDGFR alpha gene located on chromosome 4q12. This test is particularly important in the context of certain cancers, where such genetic anomalies can drive the disease process or influence treatment strategies. Fluorescence in situ hybridization (FISH) is the technology used to identify these genetic changes, offering a high degree of accuracy and specificity.
Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic capabilities, this test is an essential tool for oncologists and hematologists. It helps in the diagnosis, prognosis, and in some cases, the selection of targeted therapies for patients with conditions linked to PDGFR alpha abnormalities. The cost of the test is set at 1200 AED, reflecting the intricate processes and expertise required to accurately detect gene rearrangements. This investment can be pivotal for patients, potentially guiding more personalized and effective treatment plans.
The "FISH - PDGFR Beta 5q33 Gene Rearrangement Test" is a specialized diagnostic tool employed to detect rearrangements in the PDGFRB gene located on chromosome 5q33. This test is particularly significant in the diagnosis and management of certain hematological malignancies, where the rearrangement of the PDGFRB gene can lead to abnormal cell growth and cancer development. Fluorescence In Situ Hybridization (FISH) is the technique used in this test, offering high specificity and sensitivity in identifying genetic abnormalities at a molecular level.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test provides crucial information that aids healthcare professionals in determining the most appropriate treatment plan for patients affected by conditions associated with PDGFRB gene rearrangements. The cost of the test is set at 1200 AED, reflecting the advanced technology and expertise required to conduct this sophisticated analysis. Through this test, DNA Labs UAE contributes to the personalized approach in medicine, enabling targeted therapies that can significantly improve patient outcomes in the realm of hematologic malignancies.
The FISH (Fluorescence In Situ Hybridization) Postnatal Gender Confirmation Test is a sophisticated diagnostic procedure available at DNA Labs UAE, designed to accurately determine the gender of an infant after birth. This test utilizes the FISH technique, which involves applying fluorescent probes that bind to specific DNA sequences on chromosomes related to gender determination. By examining these chromosomes under a fluorescence microscope, technicians can confirm the gender of the newborn with high precision.
The process is non-invasive and requires only a small sample of the child's cells, typically obtained through a blood draw or a cheek swab. This makes the test not only accurate but also safe and comfortable for the infant.
Priced at 1200 AED, the FISH Postnatal Gender Confirmation Test at DNA Labs UAE is a valuable option for parents seeking confirmation of their child's gender for medical, cultural, or personal reasons. The test's cost reflects the advanced technology and expertise required to conduct it, ensuring that parents receive reliable and accurate results. DNA Labs UAE is known for its commitment to quality and accuracy, making it a trusted choice for this sensitive and important testing.
The "FISH - RARA 17q21 Variant Translocation Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting specific genetic abnormalities associated with certain types of leukemia. FISH, or Fluorescence In Situ Hybridization, is a molecular cytogenetic technique that allows scientists to visualize and map the genetic material in an individual's cells. This particular test focuses on identifying the translocation of the RARA gene located on chromosome 17q21, a genetic anomaly often associated with acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia.
The identification of the RARA gene translocation is crucial for the accurate diagnosis and treatment of APL, as it can significantly influence the therapeutic approach and the patient's prognosis. The test involves the use of fluorescent probes that bind to specific DNA sequences on chromosome 17, allowing for the precise detection of the RARA gene's location and its potential translocation.
DNA Labs UAE offers this advanced diagnostic test for a cost of 1200 AED. The facility is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring high-quality and reliable test results. By providing this test, DNA Labs UAE plays a vital role in the early detection and management of leukemia, contributing to better patient outcomes.
The FISH (Fluorescence In Situ Hybridization) - T 1221 or LSI TELAML1 Test is a highly specialized diagnostic test designed to detect genetic abnormalities associated with certain types of leukemia, specifically by identifying the translocation between chromosomes 12 and 21, denoted as t(12;21). This translocation results in the TEL-AML1 fusion gene, which is commonly associated with Acute Lymphoblastic Leukemia (ALL), particularly in pediatric cases.
The test employs fluorescence in situ hybridization technology, which uses fluorescent probes that bind to specific DNA sequences on chromosomes. This allows for the visualization of the chromosomal translocation under a fluorescence microscope. The presence of the TEL-AML1 fusion gene is a critical diagnostic marker and can influence treatment decisions and prognosis.
Conducted at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the FISH - T 1221 or LSI TELAML1 Test is priced at 1200 AED. The lab ensures accurate and reliable results, utilizing state-of-the-art technology and adhering to stringent quality controls. This test is a vital tool in the diagnosis and management of leukemia, offering crucial insights for personalized treatment plans.
The FISH - t(15;17) or LSI PML/RARA Test is a specialized diagnostic procedure utilized to detect the translocation between chromosomes 15 and 17, which results in the fusion gene PML/RARA. This genetic anomaly is primarily associated with Acute Promyelocytic Leukemia (APL), a subtype of Acute Myeloid Leukemia (AML). The test employs Fluorescence In Situ Hybridization (FISH) technology, a molecular cytogenetic technique that allows for the visualization of specific DNA sequences on chromosomes, to identify the presence of the PML/RARA fusion gene.
Conducted at DNA Labs UAE, the test is crucial for the accurate diagnosis of APL, as the presence of the PML/RARA fusion gene indicates a specific and distinct pathogenesis that requires targeted therapy. Early and precise detection through the FISH - t(15;17) test enables healthcare providers to implement the most effective treatment plan, significantly improving patient outcomes. The test cost is 1200 AED, reflecting the specialized technology and expertise required to perform this advanced diagnostic procedure.
The FISH (Fluorescence In Situ Hybridization) - t1114 or LSI IGH/CCNDI Test is a specialized diagnostic procedure offered at DNA Labs UAE. Priced at 1200 AED, this test is designed to detect genetic abnormalities associated with certain types of cancers, including some forms of leukemia and lymphoma. By using fluorescent probes that bind to specific DNA sequences on chromosome 11 and 14, the test can identify the translocation t(11;14)(q13;q32), which involves the IGH and CCND1 genes. This translocation is a critical marker for diagnosing and managing specific hematological malignancies, as it plays a significant role in the disease's development and progression. Conducted in the state-of-the-art facilities of DNA Labs UAE, the FISH - t1114 or LSI IGH/CCNDI Test provides crucial information for the accurate diagnosis and tailored treatment planning for affected patients.
